← Pharmacology

Topics

Choose a medication group to see common names, possible effects and what to check during PT.

Educational reference. Verify the patient’s actual medication and care plan; do not independently hold or change medication.

Heart rate & blood pressure

Beta blockers

Common names: metoprolol, atenolol, propranolol, carvedilol, labetalol

What you may notice: Heart rate may rise less during exercise. Fatigue, low blood pressure, or a slow pulse can affect tolerance.

During PT: Use the individualized exercise plan, perceived exertion, symptoms, and vital signs together. An age-predicted heart-rate target alone can mislead.

Read the representative DailyMed label ↗

ACE inhibitors / ARBs

Common names: ACE: lisinopril, enalapril, captopril. ARB: losartan, valsartan.

What you may notice: Both can lower blood pressure and raise potassium. ACE inhibitors may cause a dry cough.

During PT: Check symptoms with position changes. Report persistent new cough for review; do not assume all cough is medication-related. Face, tongue, or throat swelling needs emergency care.

Read the representative DailyMed label ↗

Dihydropyridine calcium channel blockers

Common names: amlodipine, nifedipine

What you may notice: Ankle swelling and dizziness may occur. Swelling alone does not establish its cause.

During PT: Note new swelling and its timing. Escalate new unilateral painful swelling or swelling with shortness of breath for prompt medical assessment.

Read the representative DailyMed label ↗

Rate-slowing calcium channel blockers

Common names: diltiazem, verapamil

What you may notice: Slow heart rate, dizziness, or conduction problems may affect activity tolerance.

During PT: Monitor pulse, blood pressure, and symptoms. Combining these drugs with a beta blocker can increase bradycardia or heart-block risk; flag symptoms to the team.

Read the representative DailyMed label ↗

Fluids & standing tolerance

Loop / thiazide diuretics

Common names: Loop: furosemide, bumetanide. Thiazide-type: hydrochlorothiazide, chlorthalidone.

What you may notice: More urination; volume depletion, low blood pressure, and electrolyte disturbances are possible.

During PT: Plan bathroom access. New cramps, unusual weakness, dizziness, or palpitations merit assessment. Follow the patient's fluid plan; do not automatically recommend extra fluids.

Read the representative DailyMed label ↗

Potassium-sparing diuretics

Common names: spironolactone, eplerenone, triamterene

What you may notice: Potassium can become too high, particularly with kidney impairment or other potassium-raising drugs. Symptoms may be absent.

During PT: Review available labs and the care plan. Flag ACE inhibitor/ARB plus potassium-sparing therapy for medication review when concerns arise. Do not recommend potassium supplements or salt substitutes.

Read the representative DailyMed label ↗

Alpha-1 blockers

Common names: doxazosin, terazosin, tamsulosin

What you may notice: Dizziness with standing or fainting can occur. Tamsulosin is often used for urinary symptoms, but orthostasis still matters.

During PT: Use gradual transitions and appropriate guarding. If dizziness occurs, stop the task, position safely, assess vital signs, and follow the clinical escalation plan.

Read the representative DailyMed label ↗

Midodrine

Common names: midodrine

What you may notice: Used for symptomatic orthostatic hypotension; it can also cause high blood pressure while lying flat.

During PT: Check the prescribed blood-pressure and positioning plan before prolonged supine treatment. Monitor symptoms and blood pressure; do not independently change dose timing.

Read the representative DailyMed label ↗

Diuretic classification reminder

Classification check: spironolactone and eplerenone block aldosterone receptors. Triamterene is potassium-sparing through a different mechanism. Loop/thiazide drugs can lower potassium; potassium-sparing drugs can raise it.

Alertness, balance & breathing

Clonidine

Common names: clonidine

What you may notice: Drowsiness, dizziness, and a slower pulse may affect participation. Abrupt withdrawal can cause rebound hypertension.

During PT: Check alertness and vital signs before challenging balance or exertion. If doses were missed and blood pressure or symptoms are concerning, contact the clinical team; do not advise abrupt stopping.

Read the representative DailyMed label ↗

Tizanidine

Common names: tizanidine

What you may notice: A muscle relaxant that can cause sedation, weakness, and low blood pressure. Other sedating drugs can add to impairment.

During PT: Check transfer safety and alertness. Tizanidine with ciprofloxacin or fluvoxamine is contraindicated: flag the combination promptly to the pharmacist/prescriber.

Read the representative DailyMed label ↗

Systemic antimuscarinics

Common names: oxybutynin, tolterodine, benztropine

What you may notice: Dry mouth, blurred vision, and confusion may affect safety. Oxybutynin can reduce sweating and increase overheating risk.

During PT: Consider vision and cognition during mobility tasks. For oxybutynin, avoid excessive heat and watch for heat intolerance. Effects vary by drug and route; inhaled agents are not equivalent.

Read the representative DailyMed label ↗

Inhaled short-acting beta-2 agonist

Common names: albuterol

What you may notice: Used for bronchospasm. Tremor, palpitations, or a faster heart rate can occur.

During PT: Ask about recent inhaler use when interpreting symptoms and heart rate. Follow the prescribed rescue plan. Worsening breathing after use or poor relief requires escalation.

Read the representative DailyMed label ↗

Clinical use & sources

A medication is one possible contributor to a symptom, not proof of its cause. Verify the actual product, complete medication list, baseline, available labs, and individual care plan with your clinical instructor. These PT considerations are educational applications of the linked labeling; the list is selective and does not include every adverse effect or interaction.

Do not independently hold or change medication. Stop activity and activate emergency care for severe chest pain, severe breathing difficulty, fainting with ongoing instability, or face/tongue/throat swelling. Follow your setting’s monitoring and escalation protocols.

Sources checked October 26, 2026. Additional ACE inhibitor safety source: lisinopril prescribing information ↗. Each group links to a representative drug label; check the label for the patient’s specific medicine.

Request a medication topic

Tell us the drug or class and the PT question you want answered. Comments are public; leave out patient details and protected course or exam questions. New commenters may need approval.